Pluristem

@Pluristem

A bio-therapeutics company developing a pipeline of products derived from human placenta - a non-controversial adult stem cell source.

Haifa, Israel
pluristem.com
Tilmeldt december 2010
41 billeder og videoer Billeder og videoer

Tweets

@Pluristem er blokeret

Er du sikker på, at du vil vise disse tweets? At vise tweets vil ikke fjerne blokering af @Pluristem.

  1. retweetede
    6. apr.

    Now at : Adaptive pathways & early market access roundtable, feat

    05.22 - 6. apr. 2016 · Detaljer
    3 retweets 2 likes
  2. 6. apr.

    Pluristem CEO Zami Aberman welcomes Japanese Ambassador, Koji Tomita to Haifa labs

    04.39 - 6. apr. 2016 · Detaljer
    1 like
  3. 1. apr.

    If you missed us at the recent ARM Investor Day conference, here is our presentation:

    Vis medie Skjul medie
    2 likes
  4. 31. mar.

    US Tests Potential Israeli Cure for Victims of 'Nuclear Terrorism':

    Vis resumé Skjul resumé
    1 retweet 1 like
  5. retweetede
    18. mar.

    . Therapeutics CEO, Zami Aberman explains to how will shape the industry

    4 retweets 1 like
  6. Pluristem fulgte , , og 6 andre
    • AJC Los Angeles
      @ajcla

      The Los Angeles office of - Enhancing the wellbeing of the Jewish people & Israel, advancing human rights & democratic values around the world.

    • Andy Kemp
      @AndyKempFSG

      Business Development Manager

  7. retweetede
    22. mar.

    . VP provides updates on PLX-PAD critical limb ischemia treatment in EU & Japan, & more

    1 retweet 1 like
  8. retweetede
    22. mar.

    Maxim's Jason Kolbert discusses ARC and radiation poisoning countermeasures

    11.16 - 22. mar. 2016 · Detaljer
    2 retweets 1 like
  9. 17. mar.

    Israeli scientists develop cure for radiation sickness:

    Vis resumé Skjul resumé
    1 retweet 1 like
  10. 11. mar.

    Pluristem in today's on 5th anniversary of Fukushima:

    Vis resumé Skjul resumé
  11. retweetede
    3. mar.

    NEW: CEO on placental stem therapy ""off the shelf"" promise

    12.20 - 3. mar. 2016 · Detaljer
    3 retweets 1 like
  12. 9. mar.

    Reuters TV covers our technology against radiation sickness:

  13. 7. mar.

    SNNLive caught up with Karine Kleinhaus from at Source Capital Disruptive Growth & Healthcare Conference NYC

    Vis medie Skjul medie
    1 like
  14. 2. mar.

    Pluristem's Radiation Antidote Bests Blockbuster Drug Neupogen:

  15. retweetede
    22. feb.

    Therapeutics Specializes in Placental Derived PLX Cells via

    08.35 - 22. feb. 2016 · Detaljer
    5 retweets 3 likes
  16. 23. feb.

    Our chairman and CEO explains to Mike Ward from Informa Pharma Insights how cell therapy will shape the industry.

    3 retweets 1 like
  17. 22. feb.

    Q&A Interview with Dr. Racheli Ofir, VP of Research & Intellectual Property at Pluristem Therapeutics:

    Vis resumé Skjul resumé
    1 retweet
  18. 22. feb.

    Dr. Racheli Ofir's Q&A interview for Bioinformant :

    Vis resumé Skjul resumé
  19. 16. feb.

    Pluristem announced that the (NIAID) will initiate studies in large animals to evaluate dosing for PLX-R18:

    1 like
  20. 10. feb.

    Pluristem Reports Second Quarter Fiscal 2016 Financial Highlights and Clinical Development Update:

    1 retweet 2 likes

@Pluristem har ikke tweetet endnu.

Indlæsning ser ud til at tage noget tid.

Twitter kan være overbelastet eller have en midlertidig forstyrrelse. Prøv igen eller besøg Twitter-status for mere information.

    Du vil måske også kunne lide

    ·